glp 1 anesthesia guidelines 2025 New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review π΄ GLP-1 RAs and Anesthesia:
Description
It acquired the company in 2020
GLP-1 receptor agonists work by mimicking the effects of 1, 2, or 3 naturally produced digestive hormones, including glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (GIP)
ASC35 is the entry from a relatively small Asian biotech, betting on a novel depot formulation that pours in as a liquid and gels in the tissue
The practical stakes for patients are enormous
doi: 10.1161/CIRCULATIONAHA.119.041730
